Trexquant Investment LP Cytokinetics Inc Transaction History

Trexquant Investment LP

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$47.86 - $75.05 $3.72 Million - $5.83 Million	-77,631 Reduced 73.14%	28,508 $1.54 Million
Q1 2024 May 14, 2024	SELL	$63.75 - $108.06 $234,026 - $396,688	-3,671 Reduced 3.34%	106,139 $7.44 Million
Q4 2023 Feb 09, 2024	BUY	$26.88 - $83.49 $2.37 Million - $7.38 Million	88,342 Added 411.51%	109,810 $9.17 Million
Q3 2023 Nov 13, 2023	BUY	$29.46 - $36.61 $632,447 - $785,943	21,468 New	21,468 $632,000
Q3 2021 Nov 12, 2021	SELL	$18.54 - $35.74 $357,191 - $688,566	-19,266 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$19.79 - $26.99 $381,274 - $519,989	19,266 New	19,266 $381,000
Q4 2020 Feb 11, 2021	SELL	$15.26 - $28.61 $474,463 - $889,542	-31,092 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$20.58 - $28.96 $221,872 - $312,217	-10,781 Reduced 25.75%	31,092 $673,000
Q2 2020 Aug 07, 2020	SELL	$11.15 - $24.64 $270,409 - $597,569	-24,252 Reduced 36.68%	41,873 $987,000
Q1 2020 May 08, 2020	BUY	$8.75 - $16.3 $310,563 - $578,535	35,493 Added 115.87%	66,125 $780,000
Q4 2019 Feb 12, 2020	BUY	$7.95 - $11.84 $243,524 - $362,682	30,632 New	30,632 $325,000
Q1 2019 May 13, 2019	SELL	$5.95 - $10.19 $261,895 - $448,523	-44,016 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$5.91 - $9.29 $260,134 - $408,908	44,016 New	44,016 $278,000
Q1 2018 May 03, 2018	SELL	$7.2 - $10.05 $104,184 - $145,423	-14,470 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$7.25 - $15.65 $28,376 - $61,254	3,914 Added 37.08%	14,470 $118,000
Q3 2017 Nov 09, 2017	BUY	$12.0 - $15.0 $126,672 - $158,340	10,556	10,556 $153,000

409

125M

4.55M

2.42M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $3.91B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.